The Marcus Center for Cellular Cures (MC3) at Duke University School of Medicine has been established to bring together physicians and faculty across medicine and engineering at Duke to develop cellular and biological therapies for autism, cerebral palsy, stroke, multiple sclerosis and related brain disorders.

In partnership with Duke’s Pratt School of Engineering and based in the Duke University School of Medicine, the Center is named to recognize the generous support over a number of years from the Marcus Foundation, an Atlanta-based philanthropic organization.